|
The following is a round-up of updates by London-listed companies, issued last Wednesday and not separately reported by Alliance News: ---------- Cardiogeni PLC - Stratford-Upon-Avon, England-based developer of cell therapy medicines to treat heart failure - Updates on its share exchange agreement with Kira Health Invest AG, announced on March 16. Cardiogeni has transferred 1.3 million shares in its subsidiary Cell Therapy Ltd to Kira, representing 67.5% of its total share capital. Cardiogeni will retain a 32.5% stake in Cell Therapy. In exchange, Cardiogeni subsidiary Celixir Ltd receives 3,250 shares of Lumen Clinics BV, representing 32.5% of its total share capital. Under the deal, Kira has agreed to loan CTL up to $25 million to execute a phase 2b study for heart failure medicine CLXR-001 in Gulf Cooperation Countries. Cardiogeni says the initial tranche of $5 million is subject to standard compliance and anti-money laundering procedures for international transfers. ‘The directors believe this process will be completed in the next few days and will update the market in due course,’ Cardiogeni says. It has received a loan guarantor letter from Kira’s principal investor for the remaining $20 million. ---------- Valereum PLC - Manchester, England-based digital asset infrastructure firm - Enters into a confidential settlement agreement with Blubird Global Inc, resolving all matters relating to its prior investment. Under the agreement, Valereum is to receive 504,824 shares in Blubird, representing around 5.66% of its fully diluted share capital. In addition, it will receive 2.0 BLU tokens, to be released on a linear basis over 24 months. ‘The agreement terminates the previous investment agreements between the parties and constitutes a full and final settlement of all claims. The settlement includes customary mutual releases and does not constitute an admission of liability,’ Valereum says. ---------- Ajax Resources PLC - natural resources investment company focused on South America - Updates on the proposed acquisition of the Paguanta Project in Chile from Asara Resources Ltd. Ajax and the Vendor have agreed an extension of Ajax’s exclusivity on the acquisition until May 15. Says both parties are working towards completion. ---------- Avacta Group PLC - London-based biopharmaceutical company developing a tumour-activated oncology delivery platform - Gives two presentations at the American Association for Cancer Research Annual Meeting 2026. The presentations include the first in vivo efficacy and exposure pharmacology for its pre|CISION dual payload technology program and updated pharmacology and preclinical exposure data analyses highlighting the favorable delivery profile of AVA6103 (FAP-Exd), its second clinical candidate, which has recently entered phase 1 development. Updates to the ongoing phase 1 clinical trial are also being presented. Christina Coughlin, chief executive officer, says: ‘The data being presented at AACR underline the potential of our pre|CISION technology and AVA6103 to make a considerable difference to cancer patients. These observations could significantly increase the probability of success with AVA6103, given both the ability of FAP-Exd to deliver more payload selectively to the tumor in the preclinical setting, and the success of Enhertu in the clinic. The FOCUS-01 phase 1 clinical trial of AVA6103, now underway in the US, is designed to demonstrate the benefits of pre|CISION in unlocking the full potential of exatecan while minimizing systemic toxicity.’ ---------- Idox PLC - Woking, Surrey-based software company focuses on government services - Frankel UK Bidco Ltd’s offer for Idox is now unconditional. As at April 20, valid acceptances have been received in respect of a total of 284.1 million Idox shares, representing approximately 61.53% of Idox’s share capital. ---------- Rockfire Resources PLC - London-based mining firm targets metals and critical minerals, with assets in Australia as well as Greece - Updates on its 100%-owned Molaoi zinc deposit in Greece. Says diamond drilling to upgrade the inferred resource to indicated resource status continues with hole HMO-015 successfully completed and drilling of hole HMO-016 currently in progress. Says a strong zone of mineralisation was intersected in hole HMO-015 based on portable X-Ray Florescence readings of drill core. Individual, peak, spot pXRF readings include 47.7% zinc, 134 grams per ton silver and 2.6% lead at approximately 350 metres depth below surface. Core samples from hole HMO-015 have been sent to the laboratory for analysis. Also reports results from hole HMO-011. These include 2.0 metres at 5.13% zinc, 20.2 g/t germanium, 27.4 g/t silver and 1.33% lead. Notes that the interval commences at 36.10 metres below surface, with the highest individual assay in the interval being 1.1 metres at 9.12% zinc and 30.0g/t germanium. ---------- Vaalco Energy Inc - Canada and Africa-focused hydrocarbon explorer - Announces positive operational updates in Gabon regarding the ongoing drilling program. Says at the Etame 14H development, it has achieved an ‘excellent’ initial flow rate of 4,850 gross barrels of oil per day, with 2,850 bopd net to Vaalco. Additionally, it has encountered 325 meters of net pay in high-quality Gamba reservoir sands with better-than-expected porosity and permeability. Further, the drilling campaign in offshore Gabon continues, with rig mobilization to the Ebouri platform and drilling having commenced on the EEBOM-5H development well. Lastly, the Baobab Ivorien floating production storage and offloading vessel has completed its 47-day tow from the Dry Dock World shipyard in Dubai, where it underwent a complete refurbishment, and arrived back in the Ivory Coast on April 2. Restart of production remains on track for the second quarter. CEO George Maxwell says: ‘We continue to see positive results from our Gabon drilling campaign....We are at a critical junction, with successes in the Gabon drilling campaign and the Baobab field returning to production, and we believe that the remainder of 2026 will be very profitable. We remain focused on execution and driving meaningful growth through our organic capital programs that we believe will translate into value for our shareholders in 2026 and beyond.’ ---------- Sunrise Resources PLC - industrial mineral projects developer - Announces a retail offer via the Winterflood Retail Access Platform to raise up to £50,000 through the issue of up to 200 million shares at 0.025 pence per share. This comes after it raised £225,000 through a placing at the same price. ---------- Griffin Mining Ltd - London-based mining investor focused on China - Completes the first production blast in Zone II, ‘marking a key milestone in the commissioning and final safety approval process of Zone II in accordance with governing Chinese regulations.’ Adds: ‘All statutory mandated mine development, totalling 19.4 kilometres and ventilation shafts totalling 625 metres, were completed on April 15. Ore is now expected to be mined continuously from Zone II for the duration of the current mining licence running to 2054.’ ---------- Acceler8 Ventures PLC - acquisition vehicle - Secured funding commitments of £1.0 million through the proposed issue of unsecured convertible loan notes to be issued to incoming investors. Proceeds are to be used for near term working capital requirements. The issuance remains conditional on approval by shareholders. ---------- Copyright 2026 Alliance News Ltd. All Rights Reserved
|
